On the basis of these experimental data, we speculated that miR‐192 could regulate the malignant phenotype of glioma cells through the EGR1‐HOXB9 loop, thereby inhibiting tumour cell proliferation, invasion and migration. Here, HOXB9 is linked to central nervous system cancer.